Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

BOTOX® Cosmetic (onabotulinumtoxinA)BOTOX® Cosmetic (onabotulinumtoxinA)
VS
SanofiSanofi
BOTOX® Cosmetic (onabotulinumtoxinA)

BOTOX® Cosmetic (onabotulinumtoxinA)

N/A

Last Update: 22/04/2026

View Profile
754/1000Fair

Please see Prescribing Information and Important Safety Information, including Boxed Warning, below. A leader in aesthetic neurotoxins for decades, BOTOX® Cosmetic is the only neurotoxin that’s FDA approved for simultaneous treatment in adults for 3 areas of the face:...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:0
Subsidiaries:18
12-month incidents
0
Known data breaches
0
Attack type number
0
Sanofi

Sanofi

46 Avenue de la Grande-Armée, Paris, France, FR, 75017

Last Update: 20/05/2026

View Profile
Between 800 and 849
http://www.sanofi.com
824/1000Good

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world,...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:91,571
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
BOTOX® Cosmetic (onabotulinumtoxinA)

BOTOX® Cosmetic (onabotulinumtoxinA)

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Sanofi

Sanofi

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for BOTOX® Cosmetic (onabotulinumtoxinA) in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sanofi in 2026.

Incidents

Incident History - BOTOX® Cosmetic (onabotulinumtoxinA) (X = Date, Y = Severity)

BOTOX® Cosmetic (onabotulinumtoxinA) cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Sanofi (X = Date, Y = Severity)

Sanofi cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
BOTOX® Cosmetic (onabotulinumtoxinA)

BOTOX® Cosmetic (onabotulinumtoxinA)

Incidents
No explicit notable incidents reported.
Sanofi

Sanofi

Incidents
No explicit notable incidents reported.

FAQ

Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has the best AI Cybersecurity Score ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has experienced more cyber incidents in the past ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has experienced more cyber incidents this year ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has experienced at least one ransomware attack ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has experienced at least one data breach ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has experienced at least one targeted cyberattack ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has experienced at least one vulnerability ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one holds the most compliance certifications ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one holds the fewest compliance certifications ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has the most subsidiaries ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) company and Sanofi company, which one has the largest number of employees ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) and Sanofi, which company holds both SOC 2 Type 1 certifications ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) and Sanofi, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - BOTOX® Cosmetic (onabotulinumtoxinA) or Sanofi ?
Which company is PCI DSS compliant - BOTOX® Cosmetic (onabotulinumtoxinA) or Sanofi ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) and Sanofi, which company complies with HIPAA regulations for healthcare data ?
Between BOTOX® Cosmetic (onabotulinumtoxinA) and Sanofi, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-58523
SUMMARY

Improper access control in Microsoft Edge for Android allows an unauthorized attacker to bypass a security feature over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-14617
SUMMARY

A security vulnerability has been detected in NousResearch hermes-agent up to 2026.4.30. Affected is the function GatewayStreamConsumer._filter_and_accumulate of the file gateway/stream_consumer.py of the component Streaming Reasoning Tag Filter. The manipulation leads to improper handling of case sensitivity. The attack may be initiated remotely. The attack's complexity is rated as high. The exploitability is told to be difficult. The exploit has been disclosed publicly and may be used. The project decided to not implement a dedicated fix: "[T]he analysis and the fix are both sound. It just lands below the bar for the maintenance cost of a duplicated scrub path."

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 3.1)
CVSS2
Base Score: 2.1
Complexity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
CVSS3
Base Score: 3.1
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
CVSS4
Base Score: 1.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
1.6
CVE-2026-58597
SUMMARY

Insufficient ui warning of dangerous operations in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-58524
SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
CVE-2026-58522
SUMMARY

Relative path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.

PUBLISHED
Date2026-07-03
UPDATED
Date2026-07-03
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
2.5